The influence of 3 different navel dips on calf health, growth performance, and umbilical infection assessed by clinical and ultrasonographic examination.
The objectives were to investigate the effect of 3 navel dips on (1) umbilical infection, (2) health events (pneumonia, diarrhea, and arthritis), and (3) average daily gain (ADG) in newborn dairy calves. A secondary aim was to compare the agreement of standardized ultrasonographic examination with clinical examination for the diagnosis of umbilical infection. In a randomized block design, newborn calves were assigned by birth order to 3 treatment groups: Navel Guard (NG; SCG-Solutions Inc., McDonough, GA), 7% iodine tincture (SI), and 2% chlorhexidine gluconate (CH). Treatment consisted of a single dip administration of the umbilicus immediately after removal of the newborn from the calving pen with 1 of the 3 navel dips. Weekly clinical examinations were carried out during the first 4wk of life with special attention being paid to the umbilicus, joints, respiratory tract, and fecal consistency, and included ultrasonographic evaluation of the umbilical structures. Body weight was assessed by using a girth tape at first and last evaluation. Multivariable logistic regression demonstrated no statistical differences in umbilical infection or health events. Multivariable linear regression analysis showed statistical differences in ADG (least squares means ± standard errors) between groups, with 494±29, 571±29, and 516±29g/d in groups NG, SI, and CH, respectively. Overall mortality during the study period was 9.5% (n=40). Postmortem examination identified diarrhea (80%) as the main disorder with 19, 4, and 9 calves in groups NG, SI, and CH, respectively. Kappa values yielded fair [0.30 (95% CI: -0.03-0.63)], good [0.61 (95% CI 0.46-0.75)], moderate [0.53 (95% CI 0.31-0.74)], and moderate [0.49 (95% CI 0.19-0.79)] agreement for detection of omphalitis between clinical and ultrasonographic evaluation in wk 1, 2, 3, and 4, respectively. Agreement was very good for detection of omphaloplebitis, with kappa values (95% CI) of 0.91 (0.80-1.00), 0.87 (0.75-0.98), and 0.90 (0.76-1.00) in wk 2, 3, and 4, respectively, when omphalophlebitis was diagnosed. We detected no difference in the effectiveness of the 3 treatments in the prevention of umbilical infection, pneumonia, diarrhea, or arthritis.